Such a phenomenon has been reported in patients with BCP ALL relapsing with CD19- leukemias after administration of CD19-CAR-T cells, with lymphoid to myeloid phenotypic switching in some cases.[21, 22, 26]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.